Pictet & Cie (Europe) Sa Recursion Pharmaceuticals, Inc. Put Options Transaction History
Pictet & Cie (Europe) Sa
- $4.93 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RXRX
# of Institutions
365Shares Held
289MCall Options Held
7.75MPut Options Held
6.1M-
Vanguard Group Inc Valley Forge, PA36.1MShares$196 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33MShares$179 Million1.38% of portfolio
-
Baillie Gifford & CO24MShares$130 Million0.09% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$94.2 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$79.8 Million0.31% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $982M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...